Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

AstraZeneca and Thermo Fisher Partner to Match Patients to Precision Therapies
BioSpace
Thu, 09/2/21 - 09:13 am
Tags:
AstraZeneca, Thermo Fisher, next-generation gene sequencing, diagnostics
After Ultomiris stumble, Alexion delivers a rare disease win for AZ
Pharmaforum
Thu, 08/26/21 - 11:09 am
Tags:
AstraZeneca, Alexion, ALXN1840, Wilson disease
Gilead, Regeneron, AstraZeneca and more encourage FDA to expand patient reported outcome guidance
Endpoints
Mon, 08/23/21 - 11:07 am
Tags:
Gilead Sciences, Regeneron, AstraZeneca, FDA, PROs, oncology, clinical trials, patient-reported outcomes
AZ’s Alexion takeover hits a snag, as Ultomiris flunks ALS trial
Pharmaforum
Sun, 08/22/21 - 09:50 pm
Tags:
AstraZeneca, Ultomiris, ALS
AstraZeneca antibody cocktail slashes risk of symptomatic COVID-19, setting up regulatory filings and a lifeline for the immunosuppressed
Fierce Biotech
Fri, 08/20/21 - 10:53 am
Tags:
AstraZeneca, antibodies, COVID-19, clinical trials, AZD7442
Study adds insight on 'rare but devastating' blood clots after AstraZeneca shot
Beckers Hospital Review
Fri, 08/13/21 - 11:00 am
Tags:
AstraZeneca, blood clots, COVID-19, vaccines
AstraZeneca and Daiichi Sankyo continue to flesh out Enhertu plans, claiming win in earlier breast cancer line
Endpoints
Mon, 08/9/21 - 10:55 am
Tags:
AstraZeneca, Daiichi Sankyo, Enhertu, breast cancer
AstraZeneca chief Soriot lends GlaxoSmithKline's Walmsley CEO wisdom, support as activist investors press for change
Fierce Pharma
Fri, 08/6/21 - 11:10 am
Tags:
Pharma CEOs, GSK, AstraZeneca, Emma Walmsley, Pascal Soriot
With an assist from AstraZeneca, the salvage crew at Sierra bets another $216M they can resurrect an old Gilead JAK drug
Endpoints
Fri, 08/6/21 - 11:07 am
Tags:
Gilead Sciences, AstraZeneca, Sierra Oncology, AZD5153, oncology
AstraZeneca's launch plan for first-in-class lupus med Saphnelo centers on patient-designed support program
Fierce Pharma
Tue, 08/3/21 - 11:13 am
Tags:
AstraZeneca, drug launches, lupus, Saphnelo, patient advocacy groups
AstraZeneca nabs FDA nod to challenge GSK's Benlysta with first-in-class lupus drug Saphnelo
Fierce Pharma
Mon, 08/2/21 - 11:08 am
Tags:
AstraZeneca, GSK, FDA, lupus, Saphnelo, systemic lupus erythematosus, Benlysta
AstraZeneca still eyes US vaccine filing despite another delay
BioPharma Dive
Thu, 07/29/21 - 11:14 am
Tags:
AstraZeneca, COVID-19, vaccines, Vaxzevria, FDA
AstraZeneca and Amgen quietly admit tezepelumab defeat as the Dupixent challenger heads to FDA
Endpoints
Thu, 07/29/21 - 11:10 am
Tags:
AstraZeneca, Amgen, tezepelumab, asthma, Dupixent, Sanofi
AZ’s COVID-19 jab sales top $1.2bn, but come at a loss
Pharmaforum
Thu, 07/29/21 - 11:01 am
Tags:
AstraZeneca, earnings, vaccines, COVID-19
AstraZeneca and mRNA COVID-19 vaccines ‘show similar safety profiles’
Biopharma Reporter
Wed, 07/28/21 - 11:24 pm
Tags:
AstraZeneca, MRNA, COVID-19, vaccines, Pfizer, BioNTech
AstraZeneca Shot Brings No Increased Blood-Clot Risk After Two Doses
Bloomberg
Wed, 07/28/21 - 10:26 am
Tags:
AstraZeneca, blood clots, vaccines, COVID-19
An AstraZeneca spinout scores a buyout option from Arena
BioPharma Dive
Wed, 07/28/21 - 10:06 am
Tags:
AstraZeneca, Aristea Therapeutics, M&A, Arena Pharmaceuticals
AstraZeneca teams up with Regeneron for obesity-busting drug pact focused on genetics
Fierce Biotech
Tue, 07/27/21 - 10:29 am
Tags:
AstraZeneca, GPR75, obesity, Regeneron
AstraZeneca's newly acquired Soliris is overpriced in myasthenia gravis, cost watchdog says
Fierce Pharma
Sun, 07/25/21 - 11:44 am
Tags:
AstraZeneca, Soliris, Alexion, drug pricing, myasthenia gravis
Wins for AstraZeneca: Diabetes Drug Approved for Teens, Covid Vaccine Effective against Delta Variant
BioSpace
Fri, 07/23/21 - 12:49 pm
Tags:
AstraZeneca, type 2 diabetes, adolescents, Bydureon BCise, vaccines

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.